Hosted on MSN
Genomic testing aids precision therapy and tissue of origin identification for cancers whose primary site is unknown
A new study highlights the potential of whole genome and transcriptome sequencing (WGTS) to improve precision treatment and identify the tissue of origin for cancers whose primary site is unknown, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback